Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 33 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 24 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
30(93.8%)
Phase 2
1(3.1%)
Phase 1
1(3.1%)
32Total
N/A(30)
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (33)

Showing 20 of 33 trials
NCT07517874Not ApplicableRecruiting

Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

Role: lead

NCT07517887Not ApplicableRecruiting

Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure

Role: lead

NCT07517913Not ApplicableNot Yet Recruiting

Cerebrospinal Fluid Kinetics of Urolithin A

Role: lead

NCT07517900Not ApplicableNot Yet Recruiting

Human Skin Safety Testing of 1 Mitopure Topical Product Using a Clinical Safety in Use Study in Healthy Volunteers

Role: lead

NCT07231783Not ApplicableRecruiting

The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults

Role: lead

NCT07060898Not ApplicableActive Not Recruiting

Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes

Role: lead

NCT07161310Not ApplicableRecruiting

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

Role: collaborator

NCT07231848Not ApplicableCompleted

Bioavailability of Four Mitopure Formulations

Role: lead

NCT07100912Not ApplicableCompleted

Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

Role: lead

NCT07118943Not ApplicableCompleted

Efficacy of Four Topical Products to Improve Skin Longevity

Role: lead

NCT04985630Not ApplicableRecruiting

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

Role: lead

NCT07096466Not ApplicableCompleted

Skin Cell Regeneration Efficacy of Cosmetic Product

Role: lead

NCT06932770Not ApplicableCompleted

Anti-aging Efficacy of Food Supplement and Cosmetic Routine

Role: lead

NCT06956625Not ApplicableCompleted

Cleansing Efficacy of Cosmetic Product

Role: lead

NCT06556706Not ApplicableCompleted

Impact of Urolithin A (Mitopure) on Mitochondrial Quality in Muscle of Frail Older Adults

Role: lead

NCT06884215Not ApplicableCompleted

Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

Role: lead

NCT06853197Not ApplicableCompleted

Bioavailability of Seven Mitopure Formulations

Role: lead

NCT06362018Not ApplicableCompleted

Bioavailability of Five Mitopure Formulations

Role: lead

NCT06619457Not ApplicableCompleted

Evaluation of the Anti-aging Efficacy of One Face Care Cosmetic Product

Role: lead

NCT05735886Not ApplicableCompleted

Urolithin A Supplementation to Boost Immune Health

Role: lead